| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |